Drug profile · INN
capromab pendetide
PROSTASCINT
capromab pendetide (PROSTASCINT) is a diagnostic agent. Route of administration: intravenous. Current US regulatory status: approved.
Drug details — capromab pendetide
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
capromab pendetide (PROSTASCINT) is a diagnostic agent. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
Mechanism of action
Diagnostic agent
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is capromab pendetide?
capromab pendetide (PROSTASCINT) is a diagnostic agent. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for capromab pendetide?
PROSTASCINT is a marketed brand name for capromab pendetide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of capromab pendetide?
capromab pendetide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.